Group One Trading’s Dyne Therapeutics DYN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$43.5K Buy
2,700
+1,900
+238% +$43.6K ﹤0.01% 5342
2026
Q2
$17.8K Sell
800
-100
-11% -$1.86K ﹤0.01% 6089
2026
Q1
$16.3K Sell
900
-900
-50% -$15.5K ﹤0.01% 6088
2025
Q4
$35.2K Buy
1,800
+500
+38% +$9.47K ﹤0.01% 5888
2025
Q3
$16.4K Buy
1,300
+300
+30% +$3.42K ﹤0.01% 6844
2025
Q2
$9.5K Sell
1,000
-2,000
-67% -$22K ﹤0.01% 6747
2025
Q1
$31.4K Buy
3,000
+1,500
+100% +$21.5K ﹤0.01% 5511
2024
Q4
$35.3K Sell
1,500
-3,500
-70% -$104K ﹤0.01% 5304
2024
Q3
$180K Buy
+5,000
New +$199K ﹤0.01% 3719
2024
Q2
– Sell
-13,900
Closed -$395K – 6895
2024
Q1
$395K Buy
13,900
+7,700
+124% +$174K ﹤0.01% 2963
2023
Q4
$82.5K Buy
6,200
+3,200
+107% +$31.3K ﹤0.01% 4625
2023
Q3
$26.9K Buy
+3,000
New +$32.3K ﹤0.01% 5642

Other funds holding DYN

Group One Trading's DYN Position: Q3 2026 in Review

Group One Trading increased its Dyne Therapeutics (DYN) stake by 357% in Q3 2026, buying an estimated $30.6K and bringing the position to 1,704 shares worth $27.5K. The position accounts for ﹤0.01% of the portfolio, ranked #5661.

Group One Trading first reported a position in DYN in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.05M in Q4 2023. 270 funds tracked by Wall St. Rank hold DYN as of Q3 2026.

  • Group One Trading held 1,704 shares of Dyne Therapeutics worth $27.5K as of Q3 2026.
  • Group One Trading bought 1,331 Dyne Therapeutics shares in Q3 2026, an estimated $30.6K.
  • Dyne Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #5661 holding.
  • Group One Trading first reported a position in Dyne Therapeutics in Q3 2023 and has held it in 12 quarters since.
  • Group One Trading's Dyne Therapeutics position peaked at $1.05M in Q4 2023.
  • 270 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.